The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response has released guidance on considerations for health care providers exploring high-flow nasal cannula therapy, a less-invasive oxygen therapy than mechanical ventilation that has shown clinically useful in treating severe and critical COVID-19 patients.

ASPR is procuring 30,000 high-flow nasal cannula kits for the Strategic National Stockpile, which the agency will pair with the stockpile’s 30,000 GM/Ventec V+Pro ventilators to provide this type of therapy. Health care facilities needing the equipment should work through their public health officials to request federal assistance from the SNS through the normal processes, the agency said. If the request is approved, ASPR will direct the SNS to deploy the needed supplies to the public health authority, which is responsible for distributing it to facilities in need.

Related News Articles

Headline
AHA, through the 100 Million Mask Challenge, continues to work with novel manufacturers and suppliers to support hospitals’ and health systems’ PPE needs. By…
Headline
Even as hospitals and health systems continue to address COVID-19 and its many challenges, they are looking for lessons learned and opportunities for the…
Headline
The AHA today urged President-elect Biden to provide strong federal leadership on the COVID-19 vaccine distribution and administration process, and it pledged…
#HealthCareInnovation Thursday Blog
Though we’re all keen to say goodbye to 2020 and get the pandemic behind us, hospitals and health systems continue to be stretched in response to an…
Headline
The AHA Jan. 26 at 11 a.m. ET is hosting a Q&A event covering what front-line health care workers need to know about infection prevention and the…
Headline
The Department of Health and Human Services yesterday updated its guidance to hospitals on the reporting of COVID-19-related data. HHS requests that…